Catalist-listed Singapore Medical Group (SMG) has reported earnings of $7.2 million for the 1HFY2021 ended June, an increase of 108.2% y-o-y.

This translates to earnings per share (EPS) of 1.49 cents for the 1HFY2021, compared to 0.79 cents the year before.

Total revenue for the period came in at $49.7 million, up 27.6% y-o-y from $38.9 million previously, due to a rise in demand for the group’s Health and Diagnostics and Aesthetics services for 1HFY2021 as compared to 1HFY2020 where operations were significantly curtailed due to the Circuit Breaker (“CB”) period in Singapore from April to June 2020. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook